Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases
This is where the marketing often gets ahead of the medicine
I've never been more nervous for a show in my life
Clin Sci (Lond, Engl: 1979)
Added to this is a theoretical tumor-growth concern, reflected in the labeled warnings of approved GHRH analogs such as tesamorelin, since IGF-1 represents a growth signal for existing cell populations
These detrimental effects are mediated by complex mechanisms, including direct hepatotoxicity, oxidative stress, immune dysregulation, oncogenic signaling, and systemic metabolic disturbances